IP Library Assignment 065928/0608
Patent Assignment
Reel/Frame 065928/0608

Merger and Change of Name

Recorded: 2023-12-21 Pages: 6
Assignors
HORIZON THERAPEUTICS, LLC
Executed: 2022-12-07
HORIZON ORPHAN LLC
Executed: 2022-12-07
Assignee
HORIZON THERAPEUTICS U.S. HOLDING LLC
1 HORIZON WAY, DEERFIELD, ILLINOIS, 60015
Covered Properties (45)
Aerosolized Fluoroquinolones and Uses Thereof
Patent: 7,838,532 →
Application: 11/436,875 →
Publication: US 2006/0276483
Methods of Treatment Using Ammonia-Scavenging Drugs
Patent: 8,642,012 →
Application: 12/350,111 →
Publication: US 2010/0008859
Topical Use of Levofloxacin for Reducing Lung Inflammation
Patent: 8,629,139 →
Application: 12/574,666 →
Publication: US 2010/0087386
Aerosol Fluoroquinolone Formulations for Improved Pharmacokinetics
Patent: 8,815,838 →
Application: 12/574,680 →
Publication: US 2010/0087416
Aerosolized Fluoroquinolones and Uses Thereof
Patent: 8,524,734 →
Application: 12/604,324 →
Publication: US 2010/0040560
Aerosolized Fluoroquinolones and Uses Thereof
Patent: 8,546,423 →
Application: 12/604,340 →
Publication: US 2010/0166673
Aerosolized Fluoroquinolones and Uses Thereof
Patent: 8,524,735 →
Application: 12/604,347 →
Publication: US 2010/0037890
Aerosolized Fluoroquinolones and Uses Thereof
Patent: 8,357,696 →
Application: 12/695,981 →
Publication: US 2010/0158957
Use of Aerosolized Levofloxacin for Treating Cystic Fibrosis
Patent: 9,700,564 →
Application: 13/412,423 →
Publication: US 2012/0276153
Methods of Therapeutic Monitoring of Nitrogen Scavenging Drugs
Patent: 8,404,215 →
Application: 13/417,137 →
Publication: US 2013/0085179
Methods of Therapeutic Monitoring of Phenylacetic Acid Prodrugs
Patent: 9,561,197 →
Application: 13/610,580 →
Publication: US 2013/0281530
Methods of Therapeutic Monitoring of Nitrogen Scavenging Drugs
Patent: 9,095,559 →
Application: 13/775,000 →
Publication: US 2013/0210914
Methods of Administering and Evaluating Nitrogen Scavenging Drugs for the Treatment of Hepatic Encephalopathy
Patent: 9,289,406 →
Application: 14/086,870 →
Publication: US 2014/0142186
Delayed Release Cysteamine Bead Formulation, and Methods of Making and Using Same
Patent: 9,233,077 →
Application: 14/306,303 →
Publication: US 2014/0370085
Methods for Analyzing Cysteamine Compositions
Patent: 9,435,785 →
Application: 14/306,820 →
Publication: US 2015/0056712
Aerosol Fluoroquinolone Formulations for Improved Pharmacokinetics
Patent: 9,326,936 →
Application: 14/333,583 →
Publication: US 2014/0329810
Delayed Release Cysteamine Bead Formulation, and Methods of Making and Using Same
Patent: 9,173,851 →
Application: 14/751,639 →
Publication: US 2015/0290139
Methods of Therapeutic Monitoring of Nitrogen Scavenging Drugs
Patent: 9,254,278 →
Application: 14/816,674 →
Publication: US 2015/0335605
Methods of Therapeutic Monitoring of Nitrogen Scavenging Drugs
Patent: 9,326,966 →
Application: 14/958,259 →
Publication: US 2016/0081969
Aerosol Fluoroquinolone Formulations for Improved Pharmacokinetics
Patent: 9,717,738 →
Application: 15/132,122 →
Publication: US 2016/0287606
Procedure for the Preparation of 4-Phenyl Butyrate and Uses Thereof
Patent: 9,914,692 →
Application: 15/164,126 →
Publication: US 2017/0342018
Ado-Resistant Cysteamine Analogs and Uses Thereof
Application: 15/201,969 →
Publication: US 2017/0002004
Fucosidase Inhibitors
Patent: 9,951,013 →
Application: 15/225,188 →
Publication: US 2017/0029376
Methods of Therapeutic Monitoring of Nitrogen Scavenging Drugs
Patent: 9,999,608 →
Application: 15/457,643 →
Publication: US 2018/0055807
Methods of Therapeutic Monitoring of Nitrogen Scavenging Drugs
Patent: 9,962,358 →
Application: 15/687,118 →
Publication: US 2018/0021291
Methods of Therapeutic Monitoring of Nitrogen Scavenging Drugs
Patent: 9,962,359 →
Application: 15/687,132 →
Publication: US 2018/0015064
Procedure for the Preparation of 4-Phenyl Butyrate and Uses Thereof
Application: 15/696,448 →
Publication: US 2017/0362160
Topical Use of Levofloxacin for Reducing Lung Inflammation
Application: 15/729,930 →
Publication: US 2018/0085462
Methods of Treating Non-Alcoholic Steatohepatitis (Nash) Using Cysteamine Compounds
Application: 15/771,947 →
Publication: US 2018/0338928
Methods of Therapeutic Monitoring of Nitrogen Scavenging Drugs
Application: 15/944,398 →
Publication: US 2018/0221324
Methods of Therapeutic Monitoring of Nitrogen Scavenging Drugs
Application: 15/944,411 →
Publication: US 2018/0235920
Methods of Therapeutic Monitoring of Nitrogen Scavenging Drugs
Application: 15/944,416 →
Publication: US 2018/0221325
Methods of Therapeutic Monitoring of Nitrogen Scavenging Drugs
Application: 15/944,422 →
Publication: US 2018/0221326
Methods of Therapeutic Monitoring of Nitrogen Scavenging Drugs
Application: 15/944,428 →
Publication: US 2018/0221327
Methods of Therapeutic Monitoring of Nitrogen Scavenging Drugs
Application: 15/980,376 →
Publication: US 2018/0263949
Treatment of Urea Cycle Disorders in Neonates and Infants
Application: 16/128,140 →
Publication: US 2019/0076386
Methods of Therapeutic Monitoring of Nitrogen Scavenging Drugs
Application: 16/194,061 →
Publication: US 2019/0125713
Aerosol Fluoroquinolone Formulations for Improved Pharmacokinetics
Application: 16/194,954 →
Publication: US 2019/0321371
Methods for Storing Cysteamine Formulations and Related Methods of Treatment
Application: 16/195,481 →
Publication: US 2019/0111008
Delayed Release Cysteamine Bead Formulation, and Methods of Making and Using Same
Application: 16/218,136 →
Publication: US 2019/0298665
Aerosolized Fluoroquinolones and Uses Thereof
Application: 16/250,520 →
Publication: US 2019/0381057
Use of Aerosolized Levofloxacin for Treating Cystic Fibrosis
Application: 16/263,886 →
Publication: US 2020/0000817
Methods for Storing Cysteamine Formulations and Related Methods of Treatment
Application: 16/402,599 →
Publication: US 2019/0358179
Procedure for the Preparation of 4-Phenyl Butyrate and Uses Thereof
Application: 16/405,523 →
Publication: US 2020/0002266
Methods for Storing Cysteamine Formulations and Related Methods of Treatment
Application: 16/685,196 →
Publication: US 2020/0261381
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 10, 2006
From: SURBER, MARK W.; BOSTIAN, KEITH A.; DUDLEY, MICHAEL N.; LOMOVSKAYA, OLGA
To: MPEX PHARMACEUTICALS, INC.
Reel/Frame 018097/0385 →
Assignment of Assignor's Interest Feb 24, 2009
From: SCHARSCHMIDT, BRUCE
To: HYPERION THERAPEUTICS
Reel/Frame 022305/0387 →
Assignment of Assignor's Interest Dec 16, 2009
From: GRIFFITH, DAVID C.; DUDLEY, MICHAEL N.; SURBER, MARK W.; BOSTIAN, KEITH A.
To: MPEX PHARMACEUTICALS, INC.
Reel/Frame 023664/0233 →
Assignment of Assignor's Interest Dec 16, 2009
From: DUDLEY, MICHAEL N.; TSIVKOVSKI, RUSLAN Y.; GRIFFITH, DAVID C.; RODNY, OLGA
To: MPEX PHARMACEUTICALS, INC.
Reel/Frame 023664/0215 →
Assignment of Assignor's Interest Sep 22, 2010
From: HYPERION THERAPEUTICS
To: UCYCLYD PHARMA, INC.
Reel/Frame 025031/0014 →
Assignment of Assignor's Interest Apr 9, 2012
From: UCYCLYD PHARMA, INC.
To: HYPERION THERAPEUTICS, INC.
Reel/Frame 028014/0894 →
Assignment of Assignor's Interest Apr 16, 2012
From: SURBER, MARK W.; BOSTIAN, KEITH A.; DUDLEY, MICHAEL N.; LOMOVSKAYA, OLGA
To: MPEX PHARMACEUTICALS, INC.
Reel/Frame 028052/0773 →
Assignment of Assignor's Interest Jul 20, 2012
From: LOUTIT, JEFFERY S.; MORGAN, ELIZABETH E.; DUDLEY, MICHAEL N.; GRIFFITH, DAVID C.
To: MPEX PHARMACEUTICALS, INC.
Reel/Frame 028597/0123 →
Assignment of Assignor's Interest Nov 21, 2012
From: SCHARSCHMIDT, BRUCE; MOKHTARANI, MASOUD
To: HYPERION THERAPEUTICS, INC.
Reel/Frame 029337/0054 →
Assignment of Assignor's Interest Aug 19, 2014
From: POWELL, KATHLENE; MUTTAVARAPU, RAMESH
To: RAPTOR PHARMACEUTICALS INC.
Reel/Frame 033561/0446 →
Assignment of Assignor's Interest Apr 8, 2015
From: SCHARSCHMIDT, BRUCE; MOKHTARANI, MASOUD
To: HYPERION THERAPEUTICS, INC.
Reel/Frame 035361/0777 →
Change of Name May 14, 2015
From: HYPERION THERAPEUTICS, INC.
To: HORIZON THERAPEUTICS, INC.
Reel/Frame 035638/0305 →
Corrective Assignment to Correct the Assignee's Name Previously Recorded at Reel: 035638 Frame: 0305. Assignor(S) Hereby Confirms the Change of Name. May 18, 2015
From: HYPERION THERAPEUTICS, INC.
To: HORIZON THERAPEUTICS, INC.
Reel/Frame 035716/0190 →
Corrective Assignment to Correct the Address of Receiving Party Previously Recorded at Reel: 035638 Frame: 0305. Assignor(S) Hereby Confirms the Change of Name. May 18, 2015
From: HYPERION THERAPEUTICS, INC.
To: HYPERION THERAPEUTICS, INC.
Reel/Frame 035716/0067 →
Confirmatory Assignment Jun 2, 2015
From: SCHARSCHMIDT, BRUCE F.
To: HORIZON THERAPEUTICS, INC.
Reel/Frame 035806/0280 →
Confirmatory Assignment Jun 2, 2015
From: MOKHTARANI, MASOUD
To: HORIZON THERAPEUTICS, INC.
Reel/Frame 035806/0362 →
Assignment of Assignor's Interest Jul 31, 2015
From: GRIFFITH, DAVID C.; DUDLEY, MICHAEL N.; SURBER, MARK W.; BOSTIAN, KEITH A.
To: MPEX PHARMACEUTICALS, INC.
Reel/Frame 036227/0778 →
Assignment of Assignor's Interest Jul 31, 2015
From: SURBER, MARK W.; BOSTIAN, KEITH A.; DUDLEY, MICHAEL N.; LOMOVSKAYA, OLGA
To: MPEX PHARMACEUTICALS, INC.
Reel/Frame 036227/0723 →
Patent Security Agreement Aug 6, 2015
From: HORIZON THERAPEUTICS, INC.
To: CITIBANK, N.A.
Reel/Frame 036314/0141 →
Assignment of Assignor's Interest Oct 28, 2015
From: MPEX PHARMACEUTICAL, INC.
To: TRIPEX PHARMACEUTICALS, LLC
Reel/Frame 036906/0924 →
Assignment of Assignor's Interest Nov 12, 2015
From: TRIPEX PHARMACEUTICALS, LLC
To: RAPTOR PHARMACEUTICALS INC
Reel/Frame 037102/0573 →
Assignment of Assignor's Interest May 3, 2016
From: POWELL, KATHLENE; MUTTAVARAPU, RAMESH
To: RAPTOR PHARMACEUTICALS INC.
Reel/Frame 038442/0947 →
Assignment of Assignor's Interest May 18, 2016
From: POWELL, KATHLENE; MUTTAVARAPU, RAMESH
To: RAPTOR PHARMACEUTICALS INC.
Reel/Frame 038632/0551 →
Change of Name Aug 9, 2016
From: HORIZON THERAPEUITCS, INC.
To: HORIZON THERAPEUTICS, LLC
Reel/Frame 039633/0851 →
Change of Name Aug 26, 2016
From: HORIZON THERAPEUTICS, INC.
To: HORIZON THERAPEUTICS, LLC
Reel/Frame 039640/0886 →